Publications by authors named "Xingyi Lou"

Claim this Profile
A
Application value and safety of trilaciclib in first-line chemotherapy combined with immunotherapy for extensive-stage small cell lung cancer: A real-world study.
Yanping Cui, Hongjuan Zhang, Lizhi Wang, Xingyi Lou

Oncol Lettยท December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis